Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19)
Stopped The study did not achieve funding or approval by the ethics committee. Once the vaccination phase was entered, the study lost validity and was not viable
Conditions
- SARS-CoV Infection
- Covid19
- Infection Viral
Interventions
- DRUG: Stabilized hypochlorous acid
- DRUG: Placebo
Sponsor
Hospital Universitario San Ignacio
Collaborators